Empagliflozin in Heart Failure Patients With Reduced Ejection Fraction: A Randomized Clinical Trial (Empire HF)
Phase of Trial: Phase II
Latest Information Update: 12 Oct 2018
At a glance
- Drugs Empagliflozin (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- Acronyms Empire HF
- 04 Oct 2018 Planned End Date changed from 1 Jan 2019 to 1 Oct 2019.
- 04 Oct 2018 Planned primary completion date changed from 1 Jan 2019 to 1 Oct 2019.
- 31 Aug 2018 Biomarkers information updated